Stock Information
Aldeyra Therapeutics Inc (ALDX)
Ticker Symbol: ALDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $327.03 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.5638
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -63.75%
Latest News
-
ALDX Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026
Wed, Apr 15, 2026 10:29 AM
-
AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade)
Thu, Apr 9, 2026 2:00 PM
Key Financials
Financial data not available